Overview

Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

Status:
Withdrawn
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the efficacy of transcranial direct current stimulation (tDCS) for the treatment of auditory hallucinations in patients currently on risperidone treatment who are experiencing recent onset psychosis.
Phase:
N/A
Details
Lead Sponsor:
Northwell Health
Treatments:
Risperidone